RAYMOND GOULD, MD
Radiation Oncology Physician in MARRERO, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: RAYMOND GOULD, MD reported a CMS MIPS final score of 96.9086 out of 100, above the 83.1 national average, and filed 78 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
RAYMOND GOULD, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
RAYMOND GOULD, MD at a glance
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Louisiana
How Radiation Oncology Physician compares to other specialties among Louisiana providers
Radiation Oncology Physician share within Louisiana
Radiation Oncology Physician is one of the more visible NUCC categories in Louisiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
RAYMOND GOULD, MD's 2023 MIPS final score plotted against the Radiation Oncology Physician national average
- MIPS Final Score
- 96.9086/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Radiation Oncology Physician) — 96.9086/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Radiation Oncology Physician US NPIs
96.9086/100 MIPS final score — 13.8 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Radiation Oncology Physician. Quality dim: 77.779.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RAYMOND GOULD, MD is a Radiation Oncology Physician provider practicing in MARRERO, Louisiana, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1679576318. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
RAYMOND GOULD, MD appears in the CMS NPPES registry as a Radiation Oncology Physician provider holding MD credentials at 1101 MEDICAL CENTER BLVD, MARRERO, LA, 70072, with a listed phone of (504) 349-1480. NPI 1679576318 was issued on 05/26/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GOULD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 78 prescription claims written by this provider, covering 46 Medicare beneficiaries and totaling roughly $2K in drug spend, split 44% brand-name and 56% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.9086/100 for the 2023 performance year (Quality 77.779), compared with the national average of 83.1.
Radiation Oncology Physician is a mid-sized specialty nationwide, with 6,018 enrolled providers across 52 states and an average of 186 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679576318 |
|---|---|
| Specialty | Radiation Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/26/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RAYMOND GOULD, MD's current license status, disciplinary history, and board certifications with the Louisiana State Board of Medical Examiners in Louisiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Brand vs generic prescribing mix · Above average
44% brand-name claims vs 56% generic, on 78 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 80
- Total Day Supply
- 1,626
- Brand vs Generic
- 44% brand / 56% generic
- Brand Drug Cost
- $907
- Generic Drug Cost
- $630
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 2.09
- Gender Split
- 57% female / 43% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Ssd Silver Sulfadiazine | 25 |
| Tamsulosin Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Radiation Oncology Physician Overview
How RAYMOND GOULD, MD fits within the Radiation Oncology Physician landscape nationally.
RAYMOND GOULD, MD's 78 claims are below the specialty average of 186.
Nearby Radiation Oncology Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as GOULD.
Compare Radiation Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Louisiana
Frequently Asked Questions
What is RAYMOND GOULD, MD's specialty? ▼
How much does RAYMOND GOULD, MD prescribe under Medicare Part D? ▼
What is RAYMOND GOULD, MD's Medicare quality score? ▼
Where is RAYMOND GOULD, MD located? ▼
What is RAYMOND GOULD, MD's NPI number? ▼
Does RAYMOND GOULD, MD prescribe more brand-name or generic drugs? ▼
How many Radiation Oncology Physician providers are there in the US? ▼
What drugs does RAYMOND GOULD, MD prescribe most often? ▼
Does RAYMOND GOULD, MD accept Medicare? ▼
How can I verify RAYMOND GOULD, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology